Izrael - hebrejčina - Ministry of Health

dexcel ltd, israel - propranolol hydrochloride - טבליה - propranolol hydrochloride 40 mg - propranolol - propranolol - management of angina pectoris, control of essential and renal hypertension, control of essential tremor, control of most forms of cardiac dysrhythmias, adjunct in the management of tachycardias and arrhythmias due to thyrotoxicosis and thyrotoxic crises, management of hypertrophic obstructive cardiomyopathy, management of pheochromocytoma (with an alpha blocker). prolol is also indicated for the long term prophylaxis after recovery from acute myocardial infarction (treatment to be initiated by a hospital physician), migrane prophylaxis.

Izrael - hebrejčina - Ministry of Health

dexcel ltd, israel - propranolol hydrochloride - טבליה - propranolol hydrochloride 10 mg - propranolol - propranolol - management of angina pectoris, control of essential and renal hypertension, control of essential tremor, control of most forms of cardiac dysrhythmias, adjunct in the management of tachycardias and arrhythmias due to thyrotoxicosis and thyrotoxic crises, management of hypertrophic obstructive cardiomyopathy, management of pheochromocytoma (with an alpha blocker). prolol is also indicated for the long term prophylaxis after recovery from acute myocardial infarction (treatment to be initiated by a hospital physician), migrane prophylaxis.

Izrael - hebrejčina - Ministry of Health

abic ltd. - propranolol hydrochloride - טבליה - propranolol hydrochloride 40 mg - propranolol - propranolol - 1. management of angina pectoris. 2. control of essential and renal hypertension essential tremor most forms of cardiac dysrhythmias. 3. as and adjunct in the management of tachycardias and arrhythmias due to thyrotoxicosis and thyrotoxic crises hypertrophic obstructive cardiomyopathy pheochromocytoma (with an alpha blocker). 4. deralin is also indicated for long term prophylaxis following recovery from acute myocardial infarction (treatment to be initiated by a hospital physician) . 5. migraine prophylaxis.

Izrael - hebrejčina - Ministry of Health

j-c health care ltd - daratumumab - תרכיז להכנת תמיסה לאינפוזיה - daratumumab 20 mg / 1 ml - daratumumab

Izrael - hebrejčina - Ministry of Health

soreq nuclear research cent./ isorad - tetrakis copper - tetrafluoroborate - אבקה מיובשת בהקפאה להזרקה - tetrakis copper - tetrafluoroborate 1 mg/vial - combinations - combinations - myocardial imaging. prognostication. pharmacologic stress. breast imaging.

Izrael - hebrejčina - Ministry of Health

isorad ltd, israel - thallium (201tl) chloride - תמיסה להזרקה - thallium (201tl) chloride - other cardiovascular system diagnostic radiopharmaceuticals - myocardial perfusion imaging.

Izrael - hebrejčina - Ministry of Health

j-c health care ltd - daratumumab - תמיסה להזרקה - daratumumab 120 mg / 1 ml - daratumumab

Izrael - hebrejčina - Ministry of Health

medison pharma ltd - amifampridine 10 mg - tablets - amifampridine - symptomatic treatment of lambert-eaton myasthenic syndrome (lems) in adults

Izrael - hebrejčina - Ministry of Health

sanofi israel ltd - clopidogrel as hydrogen sulfate - טבליות מצופות פילם - clopidogrel as hydrogen sulfate 75 mg - clopidogrel - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid

Izrael - hebrejčina - Ministry of Health

teva israel ltd - clopidogrel as bisulfate - טבליה - clopidogrel as bisulfate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows : * recent mi recent stroke or established peripheral arterial disease : - patients suffering from myocardial infarction (from a few days until less than 35 days ) - ischaemic stroke ( from 7 days until less than 6 months) or established peripheral arterial disease. - for patients with a history of recent myocardial infarction (mi) recent stroke or established peripheral arterial disease - clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not) new mi (fatal or not) and other vascular death. * acute coronary syndrome: - for patients with acute coronary syndrome [non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction ] in combination with asa in medically treated patients eligible for thrombolytic therapy and those who are to be managed with percutaneous coronary intervention (with or without stent) or